UniQure to lay off about 20% of workforce

uniQure

05/10/2023 12:19

Oct 5 (Reuters) - Dutch gene therapy maker uniQure N.V
 UQ1.F  said on Thursday it will reduce about 20% of total
workforce and discontinue investments in more than half of its
research and technology projects as part of a restructuring plan
to save costs.
    The restructuring, however, will not affect the
manufacturing of multi-million-dollar gene therapy Hemgenix for
CSL Behring, the company said.
    

 (Reporting by Mariam Sunny in Bengaluru; Editing by Sherry
Jacob-Phillips)
 ((Mariam.ESunny@thomsonreuters.com;))